Another busy day comes to an end. We hope yours was productive and even meaningful. Now, though, the time has come to gather assorted children and loose ends, so we can take stock and prepare for another day. Hope your evening is pleasant and see you in the morning...
Amgen's Denosumab Protects Bone Density: Study (Yahoo/Reuters)
Novartis Stock Jumps On Promise Of Kidney Cancer Med (Yahoo/AP)
Shingle Victims' Relatives Should Get Zostavax: Study (Bloomberg News)
What Pharma Is Donating To Asian Disasters (Yahoo/AP)
1 Comment
Hmm, I am a long term survivor of Kidney Cancer without this drug. I had Chemo, Surgery and I feel like new..
I am concerned about trying this out against a placebo, is that even ethical?
RAD001 actually has been around for quite some time, it failed in Leukemia and I hear it is failing miserably in Lymphoma. Additionally, patients who had to take the drug couldn't stay on it the side effects were horrible...
Me thinks the Novartis Share holders will have more to add to their lawsuit. What goes up artificially, must come down with a thud...